The EMA recommended that NUZ-001, formerly monepantel, be granted orphan medicinal product designation to treat ALS in Europe ...

A Phase 2 trial testing oral ROCK inhibitor Bravyl in people with ALS is now fully enrolled at its highest dosing group.

The newly combined company will focus on moving Kadimastem's AstroRx, NLS's DOXA platform, and other therapies through ...

The National Institute of Aging awarded a $7.3 million research grant for the study of NU-9 as a treatment for ...

Trace Neuroscience has launched in the U.S. with over $100 million in financing and a goal to develop its UNC13A-targeted ...

This November, I AM ALS, a nonprofit dedicated to helping people — both patients and family members — affected by amyotrophic ...

The funding will help support the Ontario Provincial ALS Program to meet the needs of the roughly 1,300 people in Ontario ...

Leal Therapeutics raised $45 million for drug development, including advancing a promising therapy into clinical trials for ...

Columnist Kristin Neva sometimes get overwhelmed by her increasing caregiver responsibilities, but it helps her to know she's not alone.

Columnist Kristin Neva and her husband with ALS are sometimes asked about the way they went about building their accessible home.

Mitochondrial genome mutations may be linked to ALS, per a study, opening the door for new ways to diagnosing and treating ...